These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6392315)

  • 41. Modifying the biological response in acute myeloid leukemia. II. Effect of BCG and leukemic cells on lymphocyte response to mitogens, and on helper and suppressor activity.
    Arends-Merino A; Giscombe R; Ogier C; Reizenstein P; Sjörgen AM; Wasserman J
    Cancer Immunol Immunother; 1982; 14(1):32-5. PubMed ID: 6218871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stimulation of human lymphocyte subpopulations by protein A from Staphylococcus aureus.
    Sumiya M; Kano S; Oshimi K; Gonda N; Takaku F
    Int Arch Allergy Appl Immunol; 1980; 61(4):394-406. PubMed ID: 6965925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of functional dendritic cells for potential use in the treatment of acute lymphoblastic leukemia.
    Pospísilová D; Borovicková J; Poloucková A; Spísek R; Sedivá A; Hrusák O; Starý J; Bartůnková J
    Cancer Immunol Immunother; 2002 Apr; 51(2):72-8. PubMed ID: 11904731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alloantisera to human leukemic blast cells: detection of leukemia-associated antigens (LAA).
    Baker MA; Falk JA; Taub RN
    Prog Clin Biol Res; 1977; 16():103-7. PubMed ID: 71741
    [No Abstract]   [Full Text] [Related]  

  • 45. Induction of NK and LAK activities in human lymphocyte culture by a cytosol fraction from leukemic myeloblasts and by monoclonal antibody CD 3.
    Soucek J; Chudomel V; Hrubá A; Lindnerová G
    Neoplasma; 1991; 38(1):33-41. PubMed ID: 2011208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variability of the alloreactive T-cell response to human leukemic blasts.
    Delain M; Tiberghien P; Racadot E; Billot M; Pariset J; Chabod J; Cahn JY; Hervé P
    Leukemia; 1994 Apr; 8(4):642-7. PubMed ID: 8152258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
    Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H
    J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
    Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
    Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2.
    Vose BM; Bonnard GD
    Int J Cancer; 1982 Jan; 29(1):33-9. PubMed ID: 6460704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
    Jahns-Streubel G; Reuter C; Unterhalt M; Schleyer E; Wörmann B; Büchner T; Hiddemann W
    Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
    Köhler T; Plettig R; Wetzstein W; Schmitz M; Ritter M; Mohr B; Schaekel U; Ehninger G; Bornhäuser M
    Stem Cells; 2000; 18(2):139-47. PubMed ID: 10742386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens.
    Mohanakumar T; Russell EC; Metzgar RS; Dunn N; Phibbs M; McWilliams NB; Maurer HM
    J Natl Cancer Inst; 1979 May; 62(5):1163-7. PubMed ID: 86633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cytopathogenic effect in vitro of human leukemic leukoblasts on fibroblasts in culture. Correlation with the stimulating effect in vitro of leukoblasts on autologous lymphocytes].
    Fellous M; Fridman WH
    C R Acad Hebd Seances Acad Sci D; 1971 Dec; 273(23):2394-7. PubMed ID: 5003409
    [No Abstract]   [Full Text] [Related]  

  • 55. Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia.
    Jurickova I; Waller EK; Yeager AM; Boyer MW
    Bone Marrow Transplant; 2002 Nov; 30(10):687-97. PubMed ID: 12420208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.
    Smit WM; Rijnbeek M; van Bergen CA; Fibbe WE; Willemze R; Falkenburg JH
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10152-7. PubMed ID: 9707616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigens associated with acute leukemia detected in the primed lymphocyte test.
    Reinsmoen NL; Kersey JH; Yunis EJ
    J Natl Cancer Inst; 1978 Mar; 60(3):537-43. PubMed ID: 146747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.
    Minagawa K; Jamil MO; Al-Obaidi M; Pereboeva L; Salzman D; Erba HP; Lamb LS; Bhatia R; Mineishi S; Di Stasi A
    PLoS One; 2016; 11(12):e0166891. PubMed ID: 27907031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demonstration of antibody-associated cellular cytotoxicity in patients with acute myelogenous leukemia before and after chemotherapy.
    Fäldt R; Ankerst J
    Int J Cancer; 1979 Jul; 24(1):17-26. PubMed ID: 289631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
    Cannistra SA; Groshek P; Griffin JD
    Leukemia; 1989 May; 3(5):328-34. PubMed ID: 2654494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.